AspenBio Pharma - Comparative Multiple Analysis

AspenBio Pharma (Comparative Multiple Analysis)

Home Comparative Index AspenBio Pharma

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Link to services page

placeholder_large_analysis.png

Improve your investment analysis with by seeing the AspenBio Pharma's Discounted Cash Flow analysis, AspenBio Pharma's Warren Buffet analysis, and AspenBio Pharma's Weighted Average Cost of Capital (WACC) Analysis.

Notes on the Comparative Multiple Analysis of AspenBio Pharma

WikiWealth compares AspenBio Pharma's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with AspenBio Pharma's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for AspenBio Pharma.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to AspenBio Pharma's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for AspenBio Pharma's Analysis


How does this work? The Comparative Investment Analysis determines the value of AspenBio Pharma by comparing AspenBio Pharma financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of AspenBio Pharma.

See the AspenBio Pharma cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in AspenBio Pharma.

Also, see the AspenBio Pharma's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and AspenBio Pharma's valuation conclusion for a quick summary.